Hyperbilirubinemia and Gilbert's syndrome in Cystic Fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor
Journal of Cystic Fibrosis · 2023
DOI: 10.1016/j.jcf.2023.06.013 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Cystic Fibrosis, 2023. Verfasst von V Terlizzi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Medicine, Cystic Fibrosis Regional Reference Center, Meyer Children's Hospital IRCCS, Florence, Italy. Electronic address: v…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Gilbert Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Paediatric Medicine, Cystic Fibrosis Regional Reference Center, Meyer Children's Hospital IRCCS, Florence, Italy. Electronic address: vito.terlizzi@meyer.it.
- Cystic Fibrosis Regional Support Center, Department of Pediatrics, ASST Spedali Civili Brescia, University of Brescia, Brescia, Italy.
- Paediatric Unit, Department of Maternal and Child health, Cystic Fibrosis Regional Reference Center, University of Naples Federico II, Naples, Italy.
- Paediatric Unit, Department of Translational Medical Sciences, Cystic Fibrosis Regional Reference Center, University of Naples Federico II, Naples, Italy.
- Department of Paediatric Medicine, Cystic Fibrosis Regional Reference Center, Meyer Children's Hospital IRCCS, Florence, Italy.
- Cystic Fibrosis Regional Reference Center, Azienda Universitaria Ospedaliera Consorziale Policlinico, Bari, Italy.
Zitieren
APA
Terlizzi, V., Timpano, S., Salvi, M., Tosco, A., Castaldo, A., Fevola, C., Leonetti, G., Vitullo, P., Sepe, A., Badolato, R., & Salvatore, D. (2023). Hyperbilirubinemia and Gilbert's syndrome in Cystic Fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.06.013
Vancouver
Terlizzi V, Timpano S, Salvi M, Tosco A, Castaldo A, Fevola C, et al. Hyperbilirubinemia and Gilbert's syndrome in Cystic Fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor. Journal of Cystic Fibrosis. 2023. doi:10.1016/j.jcf.2023.06.013
BibTeX
@article{Terlizzi2023,
author = {Terlizzi, V and Timpano, S and Salvi, M and Tosco, A and Castaldo, A and Fevola, C and Leonetti, G and Vitullo, P and Sepe, A and Badolato, R and Salvatore, D},
title = {Hyperbilirubinemia and Gilbert's syndrome in Cystic Fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor},
journal = {Journal of Cystic Fibrosis},
year = {2023},
doi = {10.1016/j.jcf.2023.06.013}
}
EUVIMED